Koppert invests in Amoéba to strengthen strategic collaboration

Share This Article

Koppert has announced its intention to invest €800,000 in Amoéba S.A., an industrial greentech company listed on the Paris Euronext Growth market. This strategic equity investment deepens their long-term collaboration, following a recently signed five-year exclusive global distribution agreement for Amoéba’s breakthrough biofungicide solution.

Advancing Sustainable Agriculture Through Strategic Partnership

The biofungicide, developed from the lysate of the amoeba Willaertia magna C2c, is designed to target fungal diseases such as Downy Mildew and Powdery Mildew in high-value crops like grapes and vegetables. This solution brings a novel mode of action to the market and addresses a major gap in current biocontrol options—particularly within Europe and the United States.

The active substance received EU approval in Q2 2024, with full product registrations anticipated by early 2026. Under the agreement, Koppert will distribute the product under its own brand across 18 European countries and the U.S. Expansion discussions are also underway for Brazil.

Strengthening Future Market Success

The €800,000 investment is part of a broader capital increase by Amoéba, aimed at scaling up production, enhancing working capital, and supporting regulatory processes. This investment aligns the two companies strategically and ensures Amoéba’s operational readiness to meet commercial demands.

“This investment underlines our deep confidence in Amoéba’s innovative approach and the strong commercial potential of this biofungicide,” said Martin Koppert, Chief Business Officer of Koppert. “We are committed to accelerating the adoption of biological solutions that help growers transition to more sustainable practices.”

“Koppert’s support—both commercially and now financially—validates the long-term value of our biocontrol technology,” added Jean-François Doucet, CEO of Amoéba. “Together, we are unlocking a new chapter in sustainable crop protection.”

This partnership marks a shared commitment to advancing biological alternatives and delivering meaningful impact in global agriculture.

Source – Koppert

Leave a Reply

Your email address will not be published. Required fields are marked *

Advanced Biostimulants Course: Unlocking BioAg Innovation with BAW Academy

Share This ArticleJoin the premier Advanced Biostimulants Course at BAW Academy this November. Master the…

Read More

New Partnership Unites Bushel Plus SmartPan™ System with John Deere Harvest Settings Automation Technology

Share This Article BRANDON, MANITOBA (December 2, 2025) – Bushel Plus Ltd., a global leader…

Read More

Nutrimite™ by Biobest: Optimizing Biocontrol with Predatory Mite Feeding

Share This ArticleNutrimite™ by Biobest: Optimizing Biocontrol with Predatory Mite Feeding Growers can significantly enhance…

Read More

Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA

Share This Article Biotalys (Euronext: BTLS) is excited to announce it has received regulatory approval…

Read More

Biotalys EVOCA Receives Historic EPA Approval as First Protein-Based Biofungicide

Share This ArticleBiotalys EVOCA Receives Historic EPA Approval as First Protein-Based Biofungicide Biotalys has achieved…

Read More

Hello Nature Unveils New Payoff: “Say hi to a healthier life”

Share This Article Hello Nature has officially entered a new era with the launch of…

Read More